Baudax Bio Reports First Quarter 2021 Financial Results

May 05, 2021 7:00am EDT

Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021

Apr 29, 2021 7:00am EDT

Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine

Apr 26, 2021 7:00am EDT

Baudax Bio Announces Partial Adjournment of Annual Meeting of Shareholders

Apr 08, 2021 4:05pm EDT

Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 01, 2021 7:00am EDT

Baudax Bio to Participate at the Oppenheimer 31st Annual Healthcare Conference

Mar 10, 2021 7:00am EST

Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer

Mar 08, 2021 7:00am EST

Baudax Bio to Present at the H.C. Wainwright Global Life Sciences Conference

Mar 02, 2021 7:00am EST

Baudax Bio Reports 2020 Annual Financial Results

Feb 16, 2021 7:00am EST

Baudax Bio to Report 2020 Annual Financial Results and Host Conference Call and Webcast on February 16, 2021

Feb 10, 2021 8:04am EST